Similar articles

• [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].

  [No authors listed] [No authors listed] Lakartidningen. 2002 Jul 11;99(28-29):3031-4. Lakartidningen. 2002. PMID: 12170514 Swedish.
• [Only two secure indications left. Changing one's view of hormone replacement therapy].

  Fath R. Fath R. Dtsch Med Wochenschr. 2003 Oct 24;128(43):2236. Dtsch Med Wochenschr. 2003. PMID: 14608994 German. No abstract available.
• [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].

  Magnusson C, Weiderpass E. Magnusson C, et al. Lakartidningen. 2001 Jan 31;98(5):418-21. Lakartidningen. 2001. PMID: 11229082 Review. Swedish.
• Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.

  Margarido PF, D'Amico E, Bagnoli VR, Fonseca AM, Halbe HW, Pinotti JA. Margarido PF, et al. Climacteric. 2002 Mar;5(1):87-9. Climacteric. 2002. PMID: 11974563 No abstract available.
• [Estrogen therapy in climacteric. Current views in an evidence-based perspective].

  Nilsson K. Nilsson K. Lakartidningen. 2001 Jul 11;98(28-29):3225-8. Lakartidningen. 2001. PMID: 11496812 Review. Swedish.